New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a finger prick is called “blood biomarker measurement.” In recent years, ...

OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...

INDIANAPOLIS (WISH) — An estimated 7.2 million Americans aged 65 years and older have Alzheimer’s dementia (equating to about 1 in 9 Americans) and this figure is expected to double by 2060. Globally, ...

CSF-ctDNA was detected in 59% of cases and showed high concordance (84%) with tumor mutations. Lower variant allelic frequency in CSF-ctDNA was associated with significantly worse survival outcomes.

Researchers have worked with global partners to identify and successfully implement an intervention package that has significantly improved the diagnosis and management of brain infections in ...

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer Patients with NSCLC who had CSF collection ...

SEATTLE — Seattle’s Woodland Park Zoo’s geriatric female jaguar is back in public view after she underwent diagnostics and treatment for a neurologic condition. Animal keepers recently noticed the ...